193 related articles for article (PubMed ID: 30279255)
1. First-line ibrutinib for Bing-Neel syndrome.
Tallant A; Selig D; Wanko SO; Roswarski J
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279255
[TBL] [Abstract][Full Text] [Related]
2. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
Hartsell L; Janes A; Larck C; Park S; Arnall JR
J Oncol Pharm Pract; 2019 Sep; 25(6):1534-1539. PubMed ID: 30760164
[TBL] [Abstract][Full Text] [Related]
3. How we manage Bing-Neel syndrome.
Castillo JJ; Treon SP
Br J Haematol; 2019 Nov; 187(3):277-285. PubMed ID: 31430829
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ibrutinib as first-line treatment of tumoral Bing-Neel syndrome.
Boudin L; Patient M; Roméo E; Bladé JS; de Jauréguiberry JP
Leuk Lymphoma; 2018 Nov; 59(11):2746-2748. PubMed ID: 29569974
[No Abstract] [Full Text] [Related]
5. Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.
Plander M; Szendrei T; Vadvári Á; Iványi J
Pathol Oncol Res; 2020 Jan; 26(1):591-592. PubMed ID: 30357751
[No Abstract] [Full Text] [Related]
6. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
Castillo JJ; Itchaki G; Paludo J; Varettoni M; Buske C; Eyre TA; Chavez JC; Shain KH; Issa S; Palomba ML; Pasvolsky O; Simpson D; Talaulikar D; Tam CS; Tedeschi A; Ansell SM; Nayak L; Treon SP
Blood; 2019 Jan; 133(4):299-305. PubMed ID: 30523119
[TBL] [Abstract][Full Text] [Related]
7. Bing-Neel Syndrome Successfully Treated with Tirabrutinib.
Oyama T; Taoka K; Chiba A; Matsuda K; Maki H; Masamoto Y; Kurokawa M
Intern Med; 2022 Dec; 61(23):3575-3579. PubMed ID: 35569989
[TBL] [Abstract][Full Text] [Related]
8. Bing-Neel syndrome: A case reports.
Demircioğlu S; Oltulu P; Emlik GD; Tekinalp A; Çeneli Ö
J Oncol Pharm Pract; 2021 Oct; 27(7):1758-1761. PubMed ID: 33356992
[TBL] [Abstract][Full Text] [Related]
9. A Case of Bing-Neel Syndrome Successfully Treated with Ibrutinib.
O'Neil DS; Francescone MA; Khan K; Alobeid B; Bachir A; O'Connor OA; Sawas A
Case Rep Hematol; 2018; 2018():8573105. PubMed ID: 30228918
[TBL] [Abstract][Full Text] [Related]
10. A man in his 70s with neurological symptoms and progressive pain during cancer therapy.
Tholin B; Köster AK; Standal PA
Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026856
[TBL] [Abstract][Full Text] [Related]
11. Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Jafri H; Khan I; Sidda A; Khan NAJ; Kheetan M; Griswold D; Pacioles T
J Investig Med High Impact Case Rep; 2021; 9():23247096211021228. PubMed ID: 34078157
[TBL] [Abstract][Full Text] [Related]
12. Rare case of Bing-Neel syndrome treated successfully with ibrutinib.
Hashmi H; Dhanoa JS; Emmons R
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243026
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Cabannes-Hamy A; Lemal R; Goldwirt L; Poulain S; Amorim S; Pérignon R; Berger J; Brice P; De Kerviler E; Bay JO; Sauvageon H; Beldjord K; Mourah S; Tournilhac O; Thieblemont C
Am J Hematol; 2016 Mar; 91(3):E17-9. PubMed ID: 26689870
[No Abstract] [Full Text] [Related]
14. Bing-Neel syndrome presenting with bilateral lumbar radiculopathy: A case report of a rare clinical entity.
Brotis AG; Palassopoulou M; Kapsalaki EZ; Paschalis T; Papastergiou V; Fountas KN
Neurocirugia (Astur : Engl Ed); 2022; 33(5):250-253. PubMed ID: 36084961
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.
Mason C; Savona S; Rini JN; Castillo JJ; Xu L; Hunter ZR; Treon SP; Allen SL
Br J Haematol; 2017 Oct; 179(2):339-341. PubMed ID: 27409073
[No Abstract] [Full Text] [Related]
16. [Successful treatment of Bing-Neel syndrome using combination therapy with fludarabine and rituximab].
Nagaharu K; Miyazami K; Imai H; Tamura A; Umino A; Fujieda A; Sugimoto Y; Yamaguchi M; Masuya M; Katayama N
Rinsho Ketsueki; 2014 Dec; 55(12):2423-8. PubMed ID: 25744044
[TBL] [Abstract][Full Text] [Related]
17. Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemia.
Grunenberg A; Buske C
Future Oncol; 2019 Aug; 15(23):2687-2697. PubMed ID: 31184501
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib in pretreated Waldenström's macroglobulinaemia.
Bagcchi S
Lancet Oncol; 2015 May; 16(5):e204. PubMed ID: 25892147
[No Abstract] [Full Text] [Related]
19. Bing-Neel syndrome with a paravertebral mass.
Suzuki D; Sato D; Kikuchi K; Suzuki T; Sugasawa K; Saito S; Uchimura F; Suzuki Y
Am J Med Sci; 2023 Oct; 366(4):316-320. PubMed ID: 37473959
[TBL] [Abstract][Full Text] [Related]
20. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Simon L; Fitsiori A; Lemal R; Dupuis J; Carpentier B; Boudin L; Corby A; Aurran-Schleinitz T; Gastaud L; Talbot A; Leprêtre S; Mahe B; Payet C; Soussain C; Bonnet C; Vincent L; Lissandre S; Herbrecht R; Kremer S; Leblond V; Fornecker LM
Haematologica; 2015 Dec; 100(12):1587-94. PubMed ID: 26385211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]